Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
C-MER Eye Care Holdings Limited ( (HK:3309) ) has issued an announcement.
C-MER Medical Holdings Limited has scheduled a board meeting for 27 March 2026 to review and approve the company’s audited annual results for the year ended 31 December 2025. The board will also consider whether to recommend a final dividend, a decision that could affect shareholder returns and signal management’s confidence in the company’s financial performance and cash position.
The meeting agenda additionally allows for the transaction of other business, giving the board flexibility to address further corporate matters alongside the results and dividend discussion. This upcoming session marks a key governance milestone in the company’s financial reporting cycle and may provide investors with clearer visibility on its operational trajectory and capital allocation priorities.
The most recent analyst rating on (HK:3309) stock is a Hold with a HK$1.50 price target. To see the full list of analyst forecasts on C-MER Eye Care Holdings Limited stock, see the HK:3309 Stock Forecast page.
More about C-MER Eye Care Holdings Limited
C-MER Medical Holdings Limited is a Hong Kong-listed healthcare group incorporated in the Cayman Islands, operating medical services with a focus on eye and related specialist care in the region. The company is overseen by a board comprising executive and independent non-executive directors with medical and corporate governance backgrounds.
Average Trading Volume: 371,423
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.69B
Learn more about 3309 stock on TipRanks’ Stock Analysis page.